These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 30058389)
1. Applications of MALDI-TOF mass spectrometry in clinical proteomics. Greco V; Piras C; Pieroni L; Ronci M; Putignani L; Roncada P; Urbani A Expert Rev Proteomics; 2018 Aug; 15(8):683-696. PubMed ID: 30058389 [TBL] [Abstract][Full Text] [Related]
2. Progress in proteomics for clinical microbiology: MALDI-TOF MS for microbial species identification and more. van Belkum A; Chatellier S; Girard V; Pincus D; Deol P; Dunne WM Expert Rev Proteomics; 2015; 12(6):595-605. PubMed ID: 26472137 [TBL] [Abstract][Full Text] [Related]
3. Unlocking the proteomic information encoded in MALDI-TOF-MS data used for microbial identification and characterization. Fagerquist CK Expert Rev Proteomics; 2017 Jan; 14(1):97-107. PubMed ID: 27838927 [TBL] [Abstract][Full Text] [Related]
4. Advances in MALDI mass spectrometry in clinical diagnostic applications. Ng EW; Wong MY; Poon TC Top Curr Chem; 2014; 336():139-75. PubMed ID: 23563502 [TBL] [Abstract][Full Text] [Related]
5. Matrix-assisted laser desorption ionization-time of flight mass spectrometry for the identification of bacteria and yeasts in a clinical microbiological laboratory: a review. Steensels D; Verhaegen J; Lagrou K Acta Clin Belg; 2011; 66(4):267-73. PubMed ID: 21938981 [TBL] [Abstract][Full Text] [Related]
6. Application of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) in Alzheimer's disease. Grela A; Turek A; Piekoszewski W Clin Chem Lab Med; 2012 Feb; 50(8):1297-304. PubMed ID: 22868793 [TBL] [Abstract][Full Text] [Related]
7. Biomarker Characterization by MALDI-TOF/MS. Cho YT; Su H; Wu WJ; Wu DC; Hou MF; Kuo CH; Shiea J Adv Clin Chem; 2015; 69():209-54. PubMed ID: 25934363 [TBL] [Abstract][Full Text] [Related]
8. Applications of MALDI-TOF MS in environmental microbiology. Santos IC; Hildenbrand ZL; Schug KA Analyst; 2016 May; 141(10):2827-37. PubMed ID: 27072574 [TBL] [Abstract][Full Text] [Related]
9. Proteome-based bacterial identification using matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS): A revolutionary shift in clinical diagnostic microbiology. Nomura F Biochim Biophys Acta; 2015 Jun; 1854(6):528-37. PubMed ID: 25448014 [TBL] [Abstract][Full Text] [Related]
10. Routine identification of microorganisms by matrix-assisted laser desorption ionization time-of-flight mass spectrometry: Success rate, economic analysis, and clinical outcome. Ge MC; Kuo AJ; Liu KL; Wen YH; Chia JH; Chang PY; Lee MH; Wu TL; Chang SC; Lu JJ J Microbiol Immunol Infect; 2017 Oct; 50(5):662-668. PubMed ID: 27426930 [TBL] [Abstract][Full Text] [Related]
11. Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF/TOF) platform. Pan S; Rush J; Peskind ER; Galasko D; Chung K; Quinn J; Jankovic J; Leverenz JB; Zabetian C; Pan C; Wang Y; Oh JH; Gao J; Zhang J; Montine T; Zhang J J Proteome Res; 2008 Feb; 7(2):720-30. PubMed ID: 18186601 [TBL] [Abstract][Full Text] [Related]
12. Beyond identification: emerging and future uses for MALDI-TOF mass spectrometry in the clinical microbiology laboratory. DeMarco ML; Ford BA Clin Lab Med; 2013 Sep; 33(3):611-28. PubMed ID: 23931841 [TBL] [Abstract][Full Text] [Related]
13. Current status of matrix-assisted laser desorption ionisation-time of flight mass spectrometry in the clinical microbiology laboratory. Kok J; Chen SC; Dwyer DE; Iredell JR Pathology; 2013 Jan; 45(1):4-17. PubMed ID: 23255029 [TBL] [Abstract][Full Text] [Related]
14. Rapid identification of protein biomarkers of Escherichia coli O157:H7 by matrix-assisted laser desorption ionization-time-of-flight-time-of-flight mass spectrometry and top-down proteomics. Fagerquist CK; Garbus BR; Miller WG; Williams KE; Yee E; Bates AH; Boyle S; Harden LA; Cooley MB; Mandrell RE Anal Chem; 2010 Apr; 82(7):2717-25. PubMed ID: 20232878 [TBL] [Abstract][Full Text] [Related]
15. MALDI-TOF MS as evolving cancer diagnostic tool: a review. Rodrigo MA; Zitka O; Krizkova S; Moulick A; Adam V; Kizek R J Pharm Biomed Anal; 2014 Jul; 95():245-55. PubMed ID: 24699369 [TBL] [Abstract][Full Text] [Related]
16. Optimization of analytical and pre-analytical conditions for MALDI-TOF-MS human urine protein profiles. Calvano CD; Aresta A; Iacovone M; De Benedetto GE; Zambonin CG; Battaglia M; Ditonno P; Rutigliano M; Bettocchi C J Pharm Biomed Anal; 2010 Mar; 51(4):907-14. PubMed ID: 19939598 [TBL] [Abstract][Full Text] [Related]
17. MALDI-TOF mass spectrometry tools for bacterial identification in clinical microbiology laboratory. Carbonnelle E; Mesquita C; Bille E; Day N; Dauphin B; Beretti JL; Ferroni A; Gutmann L; Nassif X Clin Biochem; 2011 Jan; 44(1):104-9. PubMed ID: 20620134 [TBL] [Abstract][Full Text] [Related]
18. Maldi-tof mass spectrometry for microorganism identification. Dingle TC; Butler-Wu SM Clin Lab Med; 2013 Sep; 33(3):589-609. PubMed ID: 23931840 [TBL] [Abstract][Full Text] [Related]
19. Identification of mammalian cell lines using MALDI-TOF and LC-ESI-MS/MS mass spectrometry. Zhang X; Scalf M; Berggren TW; Westphall MS; Smith LM J Am Soc Mass Spectrom; 2006 Apr; 17(4):490-499. PubMed ID: 16488154 [TBL] [Abstract][Full Text] [Related]
20. Rapid identification of Mycobacterium avium clinical isolates by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Lin CS; Su CC; Hsieh SC; Lu CC; Wu TL; Jia JH; Wu TS; Han CC; Tsai WC; Lu JJ; Lai HC J Microbiol Immunol Infect; 2015 Apr; 48(2):205-12. PubMed ID: 24113069 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]